WQ
BIIB icon

Wealth Quarterback’s Biogen BIIB Stock Holding History

Wealth Quarterback’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$14K Sell
49
-6
-11% -$1.97K 0.01% 403
2021
Q2 		$20K Buy
+55
New +$16.7K 0.01% 348
2020
Q2 		– Sell
-49
Closed -$15.5K – 176
2020
Q1 		$15.5K Sell
49
-22,292
-100% -$6.76M 0.01% 388
2019
Q4 		$21.7K Buy
+22,341
New +$6.2M 0.02% 336

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wealth Quarterback's BIIB Position: Q3 2021 in Review

Wealth Quarterback reduced its Biogen (BIIB) stake by 11% in Q3 2021, selling an estimated $1.97K and leaving 49 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #403.

Wealth Quarterback first reported a position in BIIB in Q4 2019 and has held it in 4 quarters since. The position peaked at $21.7K in Q4 2019. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Wealth Quarterback held 49 shares of Biogen worth $14K as of Q3 2021.
  • Wealth Quarterback sold 6 Biogen shares in Q3 2021, an estimated $1.97K.
  • Biogen made up 0.01% of Wealth Quarterback's portfolio in Q3 2021, its #403 holding.
  • Wealth Quarterback first reported a position in Biogen in Q4 2019 and has held it in 4 quarters since.
  • Wealth Quarterback's Biogen position peaked at $21.7K in Q4 2019.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.